| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Advances paid | NaN | NaN | 1,500,000 | 1,500,000 |
| Equipment, net | NaN | NaN | NaN | 0 |
| Cash | 12,207 | 13,929 | 14,391 | 31,341 |
| Prepaid expenses | 37,325 | 35,517 | 58,856 | 82,196 |
| Total current assets | 49,532 | 49,446 | 1,573,247 | 1,613,537 |
| Other non-current assets | 1,500,000 | 1,500,000 | NaN | NaN |
| Total assets | 1,549,532 | 1,549,446 | 1,573,247 | 1,613,537 |
| Note payable | NaN | 22,546 | 44,689 | 66,435 |
| Accounts payable | 737,549 | 703,812 | 923,191 | 859,925 |
| Related party payable | 4,682,455 | 4,222,838 | 3,366,503 | 3,068,028 |
| Accrued expenses | 1,875 | 1,875 | 149,774 | 153,836 |
| Total current liabilities | 5,421,879 | 4,951,071 | 4,484,157 | 4,148,224 |
| Preferred stock .001 par value 10,000,000 shares authorized none issued and outstanding | NaN | NaN | NaN | 0 |
| Total liabilities | 5,421,879 | 4,951,071 | 4,484,157 | 4,148,224 |
| Common stock .001 par value 150,000,000 shares authorized 16,072,267 shares issued and outstanding as of march 31, 2026 and 16,072,267 shares issued and outstanding as of december 31, 2025 | 16,072 | 16,072 | 16,072 | 16,072 |
| Additional paid-in capital | 6,380,607 | 6,365,446 | 6,341,773 | 6,318,099 |
| Accumulated deficit | -10,269,026 | -9,783,143 | -9,268,755 | -8,868,858 |
| Total shareholders equity | -3,872,347 | -3,401,625 | -2,910,910 | -2,534,687 |
| Total liabilities and shareholders equity | 1,549,532 | 1,549,446 | 1,573,247 | 1,613,537 |
Accustem Sciences Inc. (ACUT)
Accustem Sciences Inc. (ACUT)